tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IFRX Stock Latest News

InflaRx Regains Nasdaq Compliance with Share Price Recovery
Company AnnouncementsInflaRx Regains Nasdaq Compliance with Share Price Recovery
6d ago
6K
IFRX
InflaRx regains compliance with Nasdaq min bid price requirement
PremiumThe Fly
InflaRx regains compliance with Nasdaq min bid price requirement
7d ago
IFRX
InflaRx: Buy Rating Based on Promising C5a/C5aR Strategy and Strong Financial Position
PremiumRatings
InflaRx: Buy Rating Based on Promising C5a/C5aR Strategy and Strong Financial Position
17d ago
IFRX
InflaRx assumed with a Buy at H.C. Wainwright
PremiumThe Fly
InflaRx assumed with a Buy at H.C. Wainwright
17d ago
IFRX
InflaRx’s Hold Rating Amid Trial Delays and Uncertain Clinical Data
PremiumRatings
InflaRx’s Hold Rating Amid Trial Delays and Uncertain Clinical Data
1M ago
IFRX
InflaRx Reports Significant Losses in H1 2025 Financials
PremiumCompany AnnouncementsInflaRx Reports Significant Losses in H1 2025 Financials
1M ago
6K
IFRX
InflaRx reports Q2 EPS (21c) vs. (24c) last year
Premium
The Fly
InflaRx reports Q2 EPS (21c) vs. (24c) last year
1M ago
IFRX
InflaRx Receives Nasdaq Deficiency Notice for Share Price
Premium
Company Announcements
InflaRx Receives Nasdaq Deficiency Notice for Share Price
2M ago
6K
IFRX
InflaRx receives noncompliance notification from Nasdaq
PremiumThe Fly
InflaRx receives noncompliance notification from Nasdaq
2M ago
IFRX
InflaRx Appoints KPMG as New Auditor Following Shareholder Approval
PremiumCompany Announcements
InflaRx Appoints KPMG as New Auditor Following Shareholder Approval
3M ago
6K
IFRX
InflaRx’s Strategic Shift to INF904: A Prudent Move with Promising Prospects
PremiumRatings
InflaRx’s Strategic Shift to INF904: A Prudent Move with Promising Prospects
4M ago
IFRX
InflaRx’s Strategic Shift to INF904: A Promising Focus Amidst Early-Stage Uncertainty
PremiumRatings
InflaRx’s Strategic Shift to INF904: A Promising Focus Amidst Early-Stage Uncertainty
4M ago
IFRX
InflaRx price target lowered to $3 from $6 at Oppenheimer
PremiumThe FlyInflaRx price target lowered to $3 from $6 at Oppenheimer
4M ago
IFRX
InflaRx downgraded to Outperform from Strong Buy at Raymond James
Premium
The Fly
InflaRx downgraded to Outperform from Strong Buy at Raymond James
4M ago
IFRX
InflaRx Stock (IFRX) Plummets 55% on Clinical Failure
Premium
Market News
InflaRx Stock (IFRX) Plummets 55% on Clinical Failure
4M ago
IFRX
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
PremiumMarket News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
4M ago
M
KO
InflaRx Halts Vilobelimab Phase 3 Trial for Pyoderma Gangrenosum
PremiumCompany Announcements
InflaRx Halts Vilobelimab Phase 3 Trial for Pyoderma Gangrenosum
4M ago
6K
IFRX
InflaRx to discontinue vilobelimab indication following IDMC recommendation
PremiumThe Fly
InflaRx to discontinue vilobelimab indication following IDMC recommendation
4M ago
IFRX
InflaRx N.V. Reports Q1 2025 Financial Results
PremiumCompany Announcements
InflaRx N.V. Reports Q1 2025 Financial Results
4M ago
IFRX
InflaRx Reports Q1 2025 Financial Results with Reduced Losses
PremiumCompany AnnouncementsInflaRx Reports Q1 2025 Financial Results with Reduced Losses
4M ago
6K
IFRX
InflaRx reports Q1 EPS (EUR 0.13) vs (EUR 0.17) last year
Premium
The Fly
InflaRx reports Q1 EPS (EUR 0.13) vs (EUR 0.17) last year
4M ago
IFRX
Cantor starts InflaRx at Overweight ahead of upcoming Phase 3 data
Premium
The Fly
Cantor starts InflaRx at Overweight ahead of upcoming Phase 3 data
5M ago
IFRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >